The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Despite being one of the most preventable cancers, cervical cancer remains a leading cause of death in women worldwide, ...

Prevent cervical cancer with screenings, HPV vaccine, and healthy habits. Early detection saves lives. Empower yourself for a ...

Karnataka has initiated a focused effort to eliminate cervical cancer through a coordinated campaign involving healthcare ...

By Robert Andre Emmanuel [email protected] Antigua and Barbuda took a groundbreaking step in cervical ...

The American Cancer Society’s annual cancer trends report revealed some findings that are worrying oncologists. Experts ...

Chinese biotech Akeso (HKEX: 9926) has reported encouraging early data from a Phase III trial of its bispecific antibody ...